( May 14, 2025, 1:03 PM EDT) -- TAMPA, Fla. — A Florida federal judge on May 13 entered judgment in favor of a pharmaceutical company accused of selling unapproved compounded drugs containing semaglutide XE "semaglutide" after finding that the sole claim raised by Novo Nordisk Inc. “is moot, impliedly preempted, and fails on the merits for failure to show consumer injury.”...